About Ora Clinical
Ora Clinical is a Healthcare company based in Andover (United States) founded in 1974 by Mark Abelson. Provider of research and development services for ophthalmic drugs devices. The company has 346 employees. Its chief executive, as recorded, is Paul Colvin. Ora Clinical offers products and services including Clinical Trials Services, Endpoint Technologies, and Data and Biostatistics. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is Ora LLC. Its competitors include SpyGlass Ophthalmics, Surface Ophthalmics and Trial Runners; 2 of its 3 listed competitors have raised funding.
Company details
Ora Clinical was founded in 1974 and is located in Andover, United States. Research and development services for ophthalmic drugs and devices are delivered to start-ups and global pharmaceutical and device companies. Pre-clinical and clinical services are offered, along with unique methodologies and regulatory strategies for development. Personalized treatment plans and ongoing monitoring services are also provided in the ophthalmology sector.
- Headquarters Andover, United States
- Employees 346
- Founders Mark Abelson
- SectorsHealthcare
- Website oraclinical.com
- Social LinkedIn X
- Legal Name Ora Llc
- Investors
- Employee Count346
Products & Services of Ora Clinical
Ora Clinical offers a comprehensive portfolio of products and services, including Clinical Trials Services, Endpoint Technologies, and Data and Biostatistics.
Provides trials for ophthalmic drugs and devices globally
Offers tools for enhanced sensitivity in clinical research
Delivers precise data analysis for ophthalmic studies
Funding Insights of Ora Clinical
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Ora Clinical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | Unspecified | – | – |
1 investors in total: 1 institutional.
Investors in Ora Clinical
Ora Clinical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Vistria Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A private investment firm focused on essential industries is operated. | 2013 | vistria.com | Chicago, United States |
Investor details for Ora Clinical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ora Clinical
3 people are tracked at Ora Clinical (2 in leadership, 1 in team); the tracked headcount is 346.
| Name | Role | Group |
|---|---|---|
Mark Abelson | Founder | Leadership |
Paul Colvin | CEO | Leadership |
Stuart Abelson | Board Member | Team |
Complete people profiles for Ora Clinical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ora Clinical
2 dated milestones of Ora Clinical across 50 years, from founding to its latest funding, stage changes and deals.
- Founded Ora Clinical is founded.
- Funding First funding round.
Competitors of Ora Clinical
Ora Clinical has 3 listed competitors in our database, 2 of them funded. They include SpyGlass Ophthalmics, Surface Ophthalmics and Trial Runners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| spyglassophthalmics.com | 2019 | Mission Viejo, United States | $33.53M | Drug research and development services for ophthalmic diseases are provided. | ||
| surfaceophthalmics.com | 2020 | United States | $25M | Clinical development and research services for ophthalmology are provided. | ||
| trialrunners.com | 2006 | Dickinson, United States | 57 | Specializes in ophthalmology clinical trials and contract research services. |
Detailed competitors of Ora Clinical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ora Clinical
The website of Ora Clinical (oraclinical.com) receives about 8.4K visits a month.
- Monthly visits8.4K
▲ 4.9% vs previous month
Websites whose visitors overlap most with Ora Clinical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| telixpharma.com | 100% | 31.7K | #937,266 | View details | |
| tklresearch.com | 87% | 9.5K | #4,608,578 | View details | |
| illingworthresearch.com | 87% | 1.2K | #11,172,207 | View details | |
| premier-research.com | 87% | 39.9K | #825,378 | View details | |
| aurigaresearch.com | 87% | 21.3K | #1,485,825 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Ora Clinical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Ora Clinical (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ora Clinical
Complete news archive for Ora Clinical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ora Clinical
Ora Clinical was founded in 1974 and raised its 1st funding round 50 years after it was founded.
Ora Clinical is headquartered in Andover, United States. It is registered at Andover, Massachusetts, United States.
Paul Colvin is the CEO of Ora Clinical, as recorded in our data.
Ora Clinical has 346 employees.
Ora Clinical was founded in 1974 and is located in Andover, United States. Research and development services for ophthalmic drugs and devices are delivered to start-ups and global pharmaceutical and device companies. Pre-clinical and clinical services are offered, along with unique methodologies and regulatory strategies for development. Personalized treatment plans and ongoing monitoring services are also provided in the ophthalmology sector.
Ora Clinical's top competitors include SpyGlass Ophthalmics, Surface Ophthalmics and Trial Runners.
Ora Clinical offers Clinical Trials Services, Endpoint Technologies, and Data and Biostatistics.
Ora Clinical has 1 investor. Key investors include The Vistria Group.
Ora Clinical operates through Ora Llc.